The cardiac ablation market is on a rapid growth trajectory, with projections suggesting it will double in value by 2030. According to LSI’s Global Surgical Procedure Volumes database, approximately 1.4 million cardiac ablations were performed worldwide in 2024, with global volumes expected to grow at a CAGR of 8.8% from 2024 to 2029.
This market expansion is driven by the increasing adoption of advanced technologies, the rising prevalence of AFIB and other cardiac conditions, and the growing demand for minimally invasive procedures. Additionally, the development of next-generation devices, which come at a premium price, is fueling market growth.
In 2024, the global device ablation market (including mapping systems) was valued at $6.4 billion. It is expected to continue growing at a CAGR of 9.8%, significantly outpacing the overall cardiovascular devices market, which is growing at a slower rate of 5.8%. This is explained in detail in this article.
The concept of the WOLF™ CardioClip multifunction device has been peer-reviewed by cardiac ablation experts.
For detailed information on investing opportunities Contact Us